| Product Code: ETC6748095 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Multiple System Atrophy (MSA) Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Multiple System Atrophy (MSA) Market Revenues & Volume, 2021 & 2031F |
3.3 China Multiple System Atrophy (MSA) Market - Industry Life Cycle |
3.4 China Multiple System Atrophy (MSA) Market - Porter's Five Forces |
3.5 China Multiple System Atrophy (MSA) Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Multiple System Atrophy (MSA) Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
4 China Multiple System Atrophy (MSA) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about multiple system atrophy (MSA) in China |
4.2.2 Growing elderly population in China, who are more susceptible to MSA |
4.2.3 Technological advancements in diagnostics and treatment options for MSA |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals for MSA in China |
4.3.2 High cost associated with MSA diagnosis and treatment in China |
4.3.3 Lack of standardized treatment guidelines for MSA management in China |
5 China Multiple System Atrophy (MSA) Market Trends |
6 China Multiple System Atrophy (MSA) Market, By Types |
6.1 China Multiple System Atrophy (MSA) Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Multiple System Atrophy (MSA) Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Multiple System Atrophy (MSA) Market Revenues & Volume, By Parkinsonian, 2021- 2031F |
6.1.4 China Multiple System Atrophy (MSA) Market Revenues & Volume, By Cerebellar, 2021- 2031F |
6.2 China Multiple System Atrophy (MSA) Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 China Multiple System Atrophy (MSA) Market Revenues & Volume, By Magnetic Resonance Imaging (MRI), 2021- 2031F |
6.2.3 China Multiple System Atrophy (MSA) Market Revenues & Volume, By Positron Emission Tomography (PET), 2021- 2031F |
6.2.4 China Multiple System Atrophy (MSA) Market Revenues & Volume, By Single Photon Emission Computed Tomography (SPECT), 2021- 2031F |
6.2.5 China Multiple System Atrophy (MSA) Market Revenues & Volume, By Tilt Table Test, 2021- 2031F |
6.2.6 China Multiple System Atrophy (MSA) Market Revenues & Volume, By Others, 2021- 2031F |
7 China Multiple System Atrophy (MSA) Market Import-Export Trade Statistics |
7.1 China Multiple System Atrophy (MSA) Market Export to Major Countries |
7.2 China Multiple System Atrophy (MSA) Market Imports from Major Countries |
8 China Multiple System Atrophy (MSA) Market Key Performance Indicators |
8.1 Number of MSA awareness campaigns conducted in China |
8.2 Adoption rate of advanced diagnostic technologies for MSA in China |
8.3 Number of clinical trials for MSA treatments conducted in China |
9 China Multiple System Atrophy (MSA) Market - Opportunity Assessment |
9.1 China Multiple System Atrophy (MSA) Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Multiple System Atrophy (MSA) Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
10 China Multiple System Atrophy (MSA) Market - Competitive Landscape |
10.1 China Multiple System Atrophy (MSA) Market Revenue Share, By Companies, 2024 |
10.2 China Multiple System Atrophy (MSA) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here